Literature DB >> 17723691

Identification of P-glycoprotein substrates using open tubular chromatography on an immobilized P-glycoprotein column: Comparison of chromatographic results with Caco-2 permeability.

Ruin Moaddel1, Rachid Hamid, Sharvil Patel, Peter L Bullock, Irving W Wainer.   

Abstract

The Caco-2 cell monolayer model was used to classify 13 compounds as P-glycoprotein (Pgp) substrates or non-substrates. The apparent permeability coefficients (Papp) in the basal-to-apical direction (Papp(B-A)) and in the apical-to-basal direction (Papp(A-B)) were determined for each compound and a compound was designated as a Pgp substrate if Papp(B-A)/Papp(A-B), the permeability ratio, exceeded 2.0. The same compounds were chromatographed on open tubular glass columns containing membranes from cell lines that either expressed Pgp (Pgp+-OT column) or did not express Pgp (Pgp(-)-OT column). The differential retentions in min, Deltat values, of the compounds were determined using the following relationship Deltat=t((Pgp(+)-OT))-t((Pgp(-)-OT)). A statistically significant correlation was observed between the Deltat values and the permeability ratios, r2=0.7749 (p=0.0063), indicating that the differential chromatography approach could be used to quantitatively assess permeability ratios. The results also indicated that a Deltat value > or =0.5 min was a reliable measure of a permeability ratios >2 and could be used as a rapid qualitative determination of whether a test compound was a Pgp substrate. The chromatographic study took 1h to complete and a single pair of columns could be used to screen at least 150 compounds a week and 600 compounds during the 4-week lifetime of the columns.

Entities:  

Year:  2006        PMID: 17723691     DOI: 10.1016/j.aca.2006.03.007

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  8 in total

1.  Screening of tobacco smoke condensate for nicotinic acetylcholine receptor ligands using cellular membrane affinity chromatography columns and missing peak chromatography.

Authors:  Alexandre Maciuk; Ruin Moaddel; Jun Haginaka; Irving W Wainer
Journal:  J Pharm Biomed Anal       Date:  2007-11-26       Impact factor: 3.935

2.  The synthesis and characterization of cellular membrane affinity chromatography columns for the study of human multidrug resistant proteins MRP1, MRP2 and human breast cancer resistant protein BCRP using membranes obtained from Spodoptera frugiperda (Sf9) insect cells.

Authors:  Prateek A Bhatia; Ruin Moaddel; Irving W Wainer
Journal:  Talanta       Date:  2010-02-25       Impact factor: 6.057

Review 3.  Multiple protein stationary phases: a review.

Authors:  N S Singh; K-L Habicht; K S S Dossou; R Shimmo; I W Wainer; R Moaddel
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-04-13       Impact factor: 3.205

Review 4.  Determination and modelling of stereoselective interactions of ligands with drug transporters: a key dimension in the understanding of drug disposition.

Authors:  P Bhatia; M Kolinski; R Moaddel; K Jozwiak; I W Wainer
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

Review 5.  Comparison of analytical techniques for the identification of bioactive compounds from natural products.

Authors:  Łukasz Cieśla; Ruin Moaddel
Journal:  Nat Prod Rep       Date:  2016-07-01       Impact factor: 13.423

6.  Pharmacophore modelling of stereoselective binding to the human organic cation transporter (hOCT1).

Authors:  R Moaddel; S Ravichandran; F Bighi; R Yamaguchi; I W Wainer
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

7.  Investigation of molecular recognition in biological systems using cellular membrane affinity chromatography.

Authors:  Irving W Wainer
Journal:  Chim Oggi       Date:  2008-09

8.  Initial synthesis and characterization of an immobilized heat shock protein 90 column for online determination of binding affinities.

Authors:  Michał P Marszałł; Ruin Moaddel; Krzysztof Jozwiak; Michel Bernier; Irving W Wainer
Journal:  Anal Biochem       Date:  2007-11-06       Impact factor: 3.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.